ATE62132T1 - Etodolac mit anhaltender freigabe. - Google Patents
Etodolac mit anhaltender freigabe.Info
- Publication number
- ATE62132T1 ATE62132T1 AT88308564T AT88308564T ATE62132T1 AT E62132 T1 ATE62132 T1 AT E62132T1 AT 88308564 T AT88308564 T AT 88308564T AT 88308564 T AT88308564 T AT 88308564T AT E62132 T1 ATE62132 T1 AT E62132T1
- Authority
- AT
- Austria
- Prior art keywords
- etodolac
- weight
- continued release
- content
- ethylcellulose
- Prior art date
Links
- XFBVBWWRPKNWHW-UHFFFAOYSA-N etodolac Chemical compound C1COC(CC)(CC(O)=O)C2=N[C]3C(CC)=CC=CC3=C21 XFBVBWWRPKNWHW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005293 etodolac Drugs 0.000 title abstract 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 2
- 239000001856 Ethyl cellulose Substances 0.000 abstract 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 abstract 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 229920001249 ethyl cellulose Polymers 0.000 abstract 1
- 235000019325 ethyl cellulose Nutrition 0.000 abstract 1
- -1 hydroxypropoxyl Chemical group 0.000 abstract 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
- Ceramic Products (AREA)
- Two-Way Televisions, Distribution Of Moving Picture Or The Like (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10050187A | 1987-09-24 | 1987-09-24 | |
| EP88308564A EP0309157B1 (de) | 1987-09-24 | 1988-09-16 | Etodolac mit anhaltender Freigabe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE62132T1 true ATE62132T1 (de) | 1991-04-15 |
Family
ID=22280080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88308564T ATE62132T1 (de) | 1987-09-24 | 1988-09-16 | Etodolac mit anhaltender freigabe. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4966768A (de) |
| EP (1) | EP0309157B1 (de) |
| JP (1) | JP2879061B2 (de) |
| KR (1) | KR960009410B1 (de) |
| AT (1) | ATE62132T1 (de) |
| AU (1) | AU613663B2 (de) |
| CA (1) | CA1318600C (de) |
| DE (1) | DE3862272D1 (de) |
| DK (1) | DK168421B1 (de) |
| ES (1) | ES2021838B3 (de) |
| FI (1) | FI89005C (de) |
| GB (1) | GB2209940B (de) |
| GR (1) | GR3001739T3 (de) |
| HK (1) | HK41994A (de) |
| HU (1) | HU200920B (de) |
| IE (1) | IE60311B1 (de) |
| IL (1) | IL87757A (de) |
| MX (1) | MX171463B (de) |
| PH (1) | PH26146A (de) |
| PT (1) | PT88564B (de) |
| ZA (1) | ZA887162B (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993017673A1 (en) * | 1992-03-03 | 1993-09-16 | Top Gold Pty., Limited | Sustained release analgesics |
| US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
| US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| US6129930A (en) | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
| US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
| US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
| US5419917A (en) * | 1994-02-14 | 1995-05-30 | Andrx Pharmaceuticals, Inc. | Controlled release hydrogel formulation |
| SK74396A3 (en) * | 1995-06-13 | 1997-04-09 | American Home Prod | Organoleptically acceptable oral pharmaceutical compositions |
| PE57198A1 (es) | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
| US20060068018A1 (en) * | 1996-03-25 | 2006-03-30 | Wyeth | Extended release formulation |
| US6274171B1 (en) | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| US20030215507A1 (en) * | 1996-03-25 | 2003-11-20 | Wyeth | Extended release formulation |
| US6251430B1 (en) | 1998-02-04 | 2001-06-26 | Guohua Zhang | Water insoluble polymer based sustained release formulation |
| US6090411A (en) * | 1998-03-09 | 2000-07-18 | Temple University | Monolithic tablet for controlled drug release |
| US6106862A (en) * | 1998-08-13 | 2000-08-22 | Andrx Corporation | Once daily analgesic tablet |
| AU772891B2 (en) | 1998-12-11 | 2004-05-13 | Nostrum Pharmaceuticals, Inc. | Sustained release tablet containing hydrocolloid and cellulose ether |
| US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| US7151100B1 (en) * | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
| IN190974B (de) * | 1999-09-10 | 2003-09-06 | Ranbaxy Lab Ltd | |
| US20040152672A1 (en) * | 2000-08-09 | 2004-08-05 | Carson Dennis A. | Indole compounds useful for the treatment of cancer |
| US20070098784A1 (en) | 2001-09-28 | 2007-05-03 | Nutraceutix, Inc. | Delivery system for biological component |
| CN100478026C (zh) * | 2001-09-28 | 2009-04-15 | 纽特休迪克斯公司 | 用于生物学组分的传递系统 |
| PT1443917E (pt) * | 2001-11-07 | 2006-06-30 | Synthon Bv | Comprimidos de tamsulosina |
| IL146462A (en) * | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
| AU2003202550A1 (en) * | 2002-01-09 | 2003-07-24 | Ucb, S.A. | Pharmaceutical formulations with modified release |
| IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
| AU2003295336A1 (en) * | 2002-09-19 | 2004-04-08 | Dennis A. Carson | Use of etodoclac to treat hyperplasia |
| US6703044B1 (en) | 2002-10-25 | 2004-03-09 | Dexcel Pharma Tech, Ltd | Venlafaxine formulations |
| US7018658B2 (en) * | 2002-11-14 | 2006-03-28 | Synthon Bv | Pharmaceutical pellets comprising tamsulosin |
| US20040185097A1 (en) * | 2003-01-31 | 2004-09-23 | Glenmark Pharmaceuticals Ltd. | Controlled release modifying complex and pharmaceutical compositions thereof |
| EP2112920B1 (de) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Protonenpumpeninhibitoren enthaltende kapseln, die verschieden aufgebaute untereinheiten zur verzögerten wirkstofffreisetzung enthalten |
| US20050106253A1 (en) * | 2003-11-13 | 2005-05-19 | Platteeuw Johannes J. | Pharmaceutical pellets comprising tamsulosin |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| WO2007112581A1 (en) | 2006-04-03 | 2007-10-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
| JP5826456B2 (ja) * | 2006-04-26 | 2015-12-02 | アルファファーム ピーティーワイ リミテッド | コーティングされていない分離したユニットおよび延長放出マトリクスを含む制御放出配合物 |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| EP2026766A1 (de) | 2006-05-17 | 2009-02-25 | Synthon B.V. | Tabletten-zusammensetzung mit verlängerter freisetzung von tamsulosin |
| US8465770B2 (en) | 2008-12-24 | 2013-06-18 | Synthon Bv | Low dose controlled release tablet |
| TR200908308A1 (tr) | 2010-01-18 | 2011-08-22 | Turgut İlaçlari A.Ş. | Etodolak içeren sürekli salım tablet formulasyonu |
| CN102485215B (zh) * | 2010-12-03 | 2013-05-15 | 沈阳药科大学 | 依托度酸定时释药微丸制剂及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3939178A (en) * | 1971-06-01 | 1976-02-17 | American Home Products Corporation | Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles |
| US3954959A (en) * | 1973-03-28 | 1976-05-04 | A/S Alfred Benzon | Oral drug preparations |
| GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
| US4309406A (en) * | 1979-07-10 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4309404A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4309405A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
| US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4533551A (en) * | 1984-02-17 | 1985-08-06 | American Home Products Corporation | Method of treating arthritis with etodolac |
| US4657757A (en) * | 1985-03-29 | 1987-04-14 | Schering Corporation | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate |
-
1988
- 1988-09-07 IE IE270988A patent/IE60311B1/en not_active IP Right Cessation
- 1988-09-09 CA CA000576957A patent/CA1318600C/en not_active Expired - Lifetime
- 1988-09-13 AU AU22153/88A patent/AU613663B2/en not_active Expired
- 1988-09-15 FI FI884245A patent/FI89005C/fi not_active IP Right Cessation
- 1988-09-15 IL IL87757A patent/IL87757A/xx active Protection Beyond IP Right Term
- 1988-09-16 DE DE8888308564T patent/DE3862272D1/de not_active Expired - Lifetime
- 1988-09-16 ES ES88308564T patent/ES2021838B3/es not_active Expired - Lifetime
- 1988-09-16 AT AT88308564T patent/ATE62132T1/de not_active IP Right Cessation
- 1988-09-16 EP EP88308564A patent/EP0309157B1/de not_active Expired - Lifetime
- 1988-09-16 GB GB8821749A patent/GB2209940B/en not_active Expired - Lifetime
- 1988-09-17 JP JP63233366A patent/JP2879061B2/ja not_active Expired - Lifetime
- 1988-09-21 PT PT88564A patent/PT88564B/pt not_active IP Right Cessation
- 1988-09-21 MX MX013091A patent/MX171463B/es unknown
- 1988-09-23 KR KR88012298A patent/KR960009410B1/ko not_active Expired - Lifetime
- 1988-09-23 HU HU884992A patent/HU200920B/hu unknown
- 1988-09-23 ZA ZA887162A patent/ZA887162B/xx unknown
- 1988-09-23 DK DK531088A patent/DK168421B1/da not_active IP Right Cessation
- 1988-09-23 PH PH37584A patent/PH26146A/en unknown
- 1988-11-07 US US07/268,646 patent/US4966768A/en not_active Expired - Lifetime
-
1991
- 1991-04-04 GR GR91400364T patent/GR3001739T3/el unknown
-
1994
- 1994-04-28 HK HK41994A patent/HK41994A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE60311B1 (en) | 1994-06-29 |
| DK531088A (da) | 1989-03-25 |
| GR3001739T3 (en) | 1992-11-23 |
| PT88564B (pt) | 1992-11-30 |
| GB2209940B (en) | 1991-08-14 |
| CA1318600C (en) | 1993-06-01 |
| US4966768A (en) | 1990-10-30 |
| HK41994A (en) | 1994-05-06 |
| EP0309157B1 (de) | 1991-04-03 |
| PH26146A (en) | 1992-03-18 |
| EP0309157A1 (de) | 1989-03-29 |
| IL87757A (en) | 1992-06-21 |
| AU2215388A (en) | 1989-05-11 |
| IL87757A0 (en) | 1989-02-28 |
| IE882709L (en) | 1989-03-24 |
| ZA887162B (en) | 1990-05-30 |
| DE3862272D1 (de) | 1991-05-08 |
| ES2021838B3 (es) | 1991-11-16 |
| KR960009410B1 (en) | 1996-07-19 |
| JPH02270820A (ja) | 1990-11-05 |
| MX171463B (es) | 1993-10-28 |
| AU613663B2 (en) | 1991-08-08 |
| PT88564A (pt) | 1988-10-01 |
| FI89005C (fi) | 1993-08-10 |
| FI89005B (fi) | 1993-04-30 |
| HUT50631A (en) | 1990-03-28 |
| DK531088D0 (da) | 1988-09-23 |
| KR890004686A (ko) | 1989-05-09 |
| GB8821749D0 (en) | 1988-10-19 |
| FI884245A0 (fi) | 1988-09-15 |
| JP2879061B2 (ja) | 1999-04-05 |
| GB2209940A (en) | 1989-06-01 |
| FI884245L (fi) | 1989-03-25 |
| HU200920B (en) | 1990-09-28 |
| DK168421B1 (da) | 1994-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE62132T1 (de) | Etodolac mit anhaltender freigabe. | |
| SE8207167L (sv) | Metod for framstellning av terapeutiska foreningar med forlengd utlosningstid baserade pa hydroxypropylmetylcellulosa | |
| AU588136B2 (en) | Spray dried acetaminophen | |
| SE8104974L (sv) | Suspension av mikrokapslad bakampicillin-syraadditionssalt for oral administration, i synnerhet pa barn | |
| SE8304393L (sv) | Naproxen- och naproxennatriumtabletter av controlled release-typ | |
| EP0525389A3 (en) | Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms | |
| SE8406081L (sv) | Sett och komposition for framstellning av farmaceutiska preparat for oral administrering och med kontrollerad langtidsverkan | |
| CA2127111A1 (en) | A Method for Preparing Enteric-Coated Oral Drugs Containing Acid-Unstable Compounds | |
| SE8301579L (sv) | Metod for preparering av terapeutiska foreningar med vidmakthallande utlosning, baserade pa hydroxypropylmetylcellulosa med hog molekyler vikt | |
| DE3766200D1 (de) | L-dopa enthaltendes arzneimittel. | |
| ATE65402T1 (de) | Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung. | |
| ES2008604A6 (es) | Procedimiento de preparar aditivos para productos ingeribles y aditivo correspondiente. | |
| ES8605676A1 (es) | Formulacion de acido acetilsalicilico con efecto retardado | |
| EP0285871A3 (en) | Sustained release granulate without binding agent | |
| BG60697B2 (en) | Medicamentous form having continous release based on ethodolacquer | |
| ES2009463A6 (es) | Procedimiento de preparacion de derivados de 2-propanol. | |
| ES8502336A1 (es) | Un metodo de una preparacion de una composicion farmaceutica de base acuosa que contiene salbumatol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |